More private payers to cover tibial nerve stimulation

Article

Uroplasty, Inc. (Minneapolis) has announced that two additional private insurance payers will cover posterior tibial nerve stimulation (PTNS) using its Urgent PC Neuromodulation System for the treatment of overactive bladder and associated symptoms.

Uroplasty, Inc. (Minneapolis) has announced that two additional private insurance payers will cover posterior tibial nerve stimulation (PTNS) using its Urgent PC Neuromodulation System for the treatment of overactive bladder and associated symptoms.

Effective Aug. 1, 2011, Health Care Service Corp. will begin covering and paying for PTNS therapy for patients in Texas, Illinois, New Mexico, and Oklahoma. Additionally, effective May 18, 2011, BlueCross BlueShield of Nebraska initiated coverage of PTNS treatments.

"We have now secured coverage from three of the four largest private payers in the United States," said David Kaysen, president and CEO of Uroplasty. "We estimate that in total, the Medicare and private-pay carriers that today provide coverage for PTNS treatments represent approximately 115 million lives."

Related Videos
Illustration of Benign Prostatic Hyperplasia | Image Credit: © Judith - stock.adobe.com
Leonardo Kayat Bittencourt, MD, PhD, answers a question during a Zoom video interview
blur image background of corridor in hospital or clinic image | Image Credit @ whyframeshot - stock.adobe.com
Male and female surgeon performing surgery | Image Credit: © Georgii - stock.adobe.com
 Licensed   FILE #:  458906503  Preview Crop  Find Similar  Expand Image DIMENSIONS 8000 x 5333px FILE TYPE JPEG CATEGORY The Environment LICENSE TYPE Standard or Extended A lake in the shape of a recycling sign in the middle of untouched nature | Image Credit: © malp - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.